Is FDA’s 2013 Budget At Risk?
By Patrick O’Leary Back in February, President Obama’s FY 2013 budget authorized $4.5 billion for the Food and Drug Administration (FDA), about $2 billion of which was to come from user fees, the fees...
View ArticleThe Fallacy of Fearing “Industrialized” Medicine
By Patrick O’Leary Looking back over last month’s health-related news, two articles published on The Atlantic’s website stand out to illustrate a tension that has received a great deal of focus in...
View ArticleRegulating Compounding Pharmacies: Why An Increased FDA Role Shouldn’t Be Our...
By Patrick O’Leary A friend and I were having a conversation about health policy the other day when he observed that drug regulators like FDA face an impossible task in terms of public expectations: as...
View ArticleThe Uncertain Future of Probiotics
By Patrick O’Leary In the October 22 edition of The New Yorker, Michael Specter wrote a fascinating article about the growing and exciting science of the human microbiome, the ecosystem of ten thousand...
View ArticleThe Future of Biomedical Research Funding
By Patrick O’Leary As I’ve written about previously on this blog, the consequences for the FDA of budget sequestration under the Budget Control Act of 2011 could be fairly severe (as well as raise some...
View ArticleRegulatory Concepts in the News, Part I: FDA Efficacy Standards for Old Drugs
By Patrick O’Leary While reading some of the great articles from the health section of the New York Times over the holidays it struck me that such articles, in their need to be concise and accessible,...
View ArticleTwo Reflections on Health Law Scholarship
By Patrick O’Leary Last spring I had the chance to work as a research assistant for Marc Rodwin, a Lab Fellow at Harvard’s Edmond J. Safra Center for Ethics, reading through hundreds (perhaps...
View ArticleIrresponsible Health Reporting? The N.Y. Times and the Perpetuation of...
By Patrick O’Leary When I read Susannah Meadows’s article in last week’s New York Times Magazine, The Boy with a Thorn in His Joints, I was at a bit of a loss how to respond. The article is Meadows’s...
View ArticleTime Magazine on Solving Health Care’s #1 Problem: “All the Prices Are Too...
By Patrick O’Leary The cover story of the March 4, 2013 issue of Time Magazine is a piece by Steven Brill titled Bitter Pill: Why Medical Bills Are Killing Us. The article has apparently made a pretty...
View ArticleOn Scientific Journals as a Bulwark Against Research Misconduct
By Patrick O’Leary I’ve been thinking a lot lately about how our society regulates the integrity of scientific research in an era of fierce competition for diminishing grants and ultracompetitive...
View Article
More Pages to Explore .....